Leja M.,University of Latvia |
You W.,Peking University |
Camargo M.C.,U.S. National Cancer Institute |
Saito H.,Research Center for Cancer Prevention and Detection
Best Practice and Research: Clinical Gastroenterology | Year: 2014
Gastric cancer (GC) is still an important global healthcare problem, and in absolute figures it is going to remain at the present level in foreseeable future. In general, survival of patients with GC is poor mainly due to advanced-stage diagnosis. Early-stage GC can be cured by endoscopic resection or less invasive surgical treatment. Unfortunately, there is no appropriate screening strategy available for global application. This article provides a description of established national and regional GC screening programs and the screening modalities used. This review also summarizes current approaches to develop cancer-screening biomarkers. Although candidates with initial promising results have been suggested, moving discovery into clinical practice is still a major challenge. Well-designed biomarker studies, with systematic validation steps, are needed to decrease the burden of this fatal disease. © 2014 Elsevier Ltd. All rights reserved.